AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
ROIC: Strong ReturnsStrong
Percentile Rank33
Studio
Year-over-Year Change

Return on invested capital

Latest
-71.59%
↑ 54% vs avg
Percentile
P33
Within normal range
Streak
4 yr
Consecutive declineStrong
Average
-156.63%
Historical baseline
PeriodValueYoY Change
2025-71.59%-7.4%
2024-66.65%-19.4%
2023-55.84%-26.1%
2022-44.29%-27.1%
2021-34.84%+86.7%
2020-262.49%+53.2%
2019-560.69%-